La Quinta Columna
La Quinta Columna (English: The Fifth Column) is a Spanish independent research and journalism group founded in 2020, best known for their claim that Graphene Oxide was present in COVID-19 vaccine vials. Led by biostatistician Ricardo Delgado Martín and physician Dr. José Luis Sevillano, the group gained international attention after publishing analysis purportedly demonstrating the presence of undisclosed graphene-based materials in vaccine samples. Their work sparked significant debate within both alternative research communities and mainstream scientific circles, and contributed directly to wider investigations into the contents of COVID Vaccines and the emerging field of Intra-Body Nano Network theory.
Background and Founding
La Quinta Columna was established in Spain in late 2020, initially as a commentary platform responding to the COVID-19 Pandemic and the governmental response to it. The group operated primarily through online broadcasts, social media channels, and their website, building an audience across Spanish-speaking countries and eventually attracting international attention through translation networks.
Ricardo Delgado Martín, the group's primary spokesperson and strategist, holds a background in biostatistics and biological analysis. Dr. José Luis Sevillano is a practising physician who contributed medical interpretation and clinical context to the group's findings. Together, they positioned themselves as citizen researchers willing to ask questions they believed were being suppressed by mainstream institutions.
The name "La Quinta Columna" is a reference to a covert group operating within a larger body — in this case, implying that they were exposing an agenda operating from within the institutions trusted to protect public health.
The Graphene Oxide Claim
In June 2021, La Quinta Columna published what became their most widely circulated claim: that Graphene Oxide had been identified in samples from the Pfizer-BioNTech COVID-19 vaccine. Their initial report alleged that graphene oxide constituted the majority of the contents of certain vaccine vials — a claim that, if accurate, would have represented a profound undisclosed ingredient in a product administered to billions of people.
The group collaborated with Dr. Pablo Campra, a materials scientist at the University of Almería in Spain, who produced a technical report in late 2021 using optical microscopy and micro-Raman spectroscopy to analyse the samples. Campra's report, published through the platform Corona2Inspect, claimed to identify structures consistent with graphene and reduced graphene oxide in the biological material examined.
Methodology
The analytical techniques employed included:
- Optical microscopy — to visually identify unusual structures and morphologies within the liquid samples
- Micro-Raman spectroscopy — a technique that can identify carbon-based nanomaterials through their characteristic spectral signatures (specifically the D and G bands associated with graphene)
- Transmission Electron Microscopy (TEM) — used in follow-up analyses to image nanoscale structures
Campra's methodology and findings were documented in a series of technical reports which the group circulated widely. Supporters argued that the Raman spectral data was compelling; critics argued that the sampling chain was unverified, and that similar Raman signals can arise from other carbonaceous contaminants.
Link to 5G and Electromagnetic Activation
A central pillar of La Quinta Columna's theoretical framework is the proposition that graphene oxide within the human body can be activated or excited by electromagnetic frequencies — specifically those associated with 5G networks. According to this model, graphene oxide, being an excellent electromagnetic radiation absorber and conductor, could function as an antenna or receiver when introduced into biological tissue.
The group proposed that this interaction could explain a range of phenomena they attributed to vaccine recipients, including unusual electrical conductivity in the blood, neurological symptoms, and the formation of Self-Assembling Nanostructures visible in blood samples. They further suggested that the graphene component could interface with cellular biology to form the substrate for an Intra-Body Nano Network — a proposed internal communications mesh that, theoretically, could receive external signals and monitor or influence physiological processes.
This hypothesis connected their work to broader discussions around the Transhumanist Agenda, including concerns raised by other researchers about undisclosed Nanotechnology in public health interventions.
International Reception
La Quinta Columna's initial report spread rapidly through alternative media networks in 2021. The work was translated into English, French, German, Portuguese, and other languages within days of its publication. Several high-profile alternative researchers and commentators cited the group's findings as confirmation of suspicions about undisclosed ingredients in the COVID vaccines.
Researchers such as Dr. Ana Maria Mihalcea and others working on Self-Assembling Nanostructures in blood samples referenced the graphene oxide hypothesis as a possible explanatory mechanism for anomalous structures they observed. The Spanish group's findings became a significant node in the international network of independent COVID vaccine research.
The group also received attention from broader platforms covering topics including Neuroweapons, Brain-Computer Interface technologies, and the Internet of Bodies, as commentators drew connections between graphene's properties and surveillance-capable nanotechnology.
Spanish-Language Impact
Within Spain and Latin America, La Quinta Columna developed a substantial following. Their broadcasts regularly attracted tens of thousands of live viewers, and their Telegram channels accumulated large subscriber bases. Some Spanish-speaking physicians and scientists publicly supported their call for independent investigation, though few credentialed researchers were willing to formally endorse the full scope of their conclusions.
Mainstream Scientific Response
Mainstream scientific and regulatory institutions largely rejected or ignored La Quinta Columna's graphene oxide claims. Responses included:
- Reuters and AFP Fact-Checks — classified the graphene oxide claim as "false", citing statements from Pfizer and independent laboratory analyses that found no graphene oxide in the vaccine formulations
- Vaccine manufacturers — Pfizer and other producers formally denied that graphene oxide was present in any form in their products
- Academic reviewers — pointed out that the Raman spectroscopy results in Campra's report were not conclusive, arguing the spectral peaks could correspond to other organic or carbonaceous materials and that the chain of custody for the analysed samples had not been independently verified
However, some researchers noted that mainstream rebuttals primarily consisted of manufacturer denials and did not produce independent peer-reviewed spectroscopic analyses of the specific samples in question. Critics of the rebuttals argued that proper scientific protocol would require direct testing of unopened vials with verified lot numbers under independent laboratory conditions — a process that was not publicly documented at the time.
Dr. Pablo Campra and the Almería Reports
Dr. Pablo Campra played the most technically significant role in La Quinta Columna's research output. His academic background in materials engineering gave the group's claims a degree of technical credibility that distinguished them from purely anecdotal reports. His official reports — released through the Corona2Inspect platform — provided the raw spectroscopic data that formed the evidentiary backbone of the graphene claim.
Campra subsequently released multiple versions of his technical report, refining his analysis and responding to criticisms. He maintained that the Raman spectral evidence was consistent with graphene-family materials and called for official replication studies by independent certified laboratories. These calls were not taken up by any government regulatory body publicly.
Ongoing Research Activities
Beyond the initial graphene oxide report, La Quinta Columna continued to produce research content throughout 2022, 2023, and into 2024. Their ongoing work included:
- Analysis of anomalous structures in the blood of vaccinated individuals, contributing to the wider discussion around Self-Assembling Nanostructures
- Commentary on the potential role of Graphene and graphene derivatives as components of a proposed Intra-Body Nano Network
- Investigation of Lipid Nanoparticles and their potential to carry undisclosed payloads
- Discussion of biosensor and bioelectronic possibilities enabled by conductive nanomaterials in biological tissue
- Ongoing broadcasts and educational content linking their findings to broader Nanotechnology and Biosurveillance concerns
The group has also addressed the legal and ethical dimensions of their claims, advocating for criminal investigations into what they characterise as unlawful medical experimentation on uninformed populations — invoking the principle of Bodily Autonomy and informed consent in medical practice.
Significance in Alternative Research
Regardless of the ultimate resolution of the graphene oxide debate, La Quinta Columna occupies a historically significant position in the landscape of independent COVID vaccine research. They were among the first groups to systematically apply materials science analytical methods to vaccine samples and to publicly publish the results. Their methodology, however contested, pushed the conversation beyond anecdote and into technical territory that required technical rebuttals rather than simple dismissal.
Their work has been cited extensively in:
- Independent journalism covering COVID Vaccines and undisclosed ingredients
- Research into Graphene in Vaccines and DNA Nanotechnology
- Theoretical frameworks around the Internet of Bodies and biological surveillance
- Discussions of potential links between public health policy and the Transhumanist Agenda
